LEWY BODY DISEASES WITH DEMENTIA - PATHOPHYSIOLOGY AND TREATMENT

被引:17
作者
CUMMINGS, JL
机构
[1] UNIV CALIF LOS ANGELES, SCH MED, DEPT PSYCHIAT & BIOBEHAV SCI, LOS ANGELES, CA 90024 USA
[2] W LOS ANGELES VET AFFAIRS MED CTR, PSYCHIAT SERV, BEHAV NEUROSCI SECT, LOS ANGELES, CA 90073 USA
关键词
D O I
10.1006/brcg.1995.1257
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
There are four major Lewy body disorders with dementia: Parkinson's disease (PD), PD with Alzheimer's disease (AD), cortical Lewy bodies and neuritic plaques, and cortical Lewy bodies and no concomitant AD-type pathology. A variety of pathogenetic processes may underly this panoply of diseases including oxidative stress, excitatory amino acid toxicity, amyloidogenesis, neurofibrillary tangle formation, inflammation, apoptotic cell death, and neurotransmitter deficiency. Treatment strategies include transmitter replacement, neuroprotection, agents to limit AD-type pathology, iron chelation, and anti-inflammatory drugs. Patients with Lewy body disorders exhibit cognitive decline resulting from a variety of disease processes and treatment must address the disease-specific pathogenesis. (C) 1995 Academic Press, Inc.
引用
收藏
页码:266 / 280
页数:15
相关论文
共 69 条
[31]  
JELLINGER K, 1989, PARKINSONISM AGING, P35
[32]  
JELLINGER K, 1989, EARLY DIAGNOSIS PREV, P171
[33]  
JELLINGER KA, 1993, MENTAL DYSFUNCTION P, P141
[34]   NEUROPROTECTIVE EFFECTS OF GLUTAMATE ANTAGONISTS AND EXTRACELLULAR ACIDITY [J].
KAKU, DA ;
GIFFARD, RG ;
CHOI, DW .
SCIENCE, 1993, 260 (5113) :1516-1518
[35]   BCL-2 INHIBITION OF NEURAL DEATH - DECREASED GENERATION OF REACTIVE OXYGEN SPECIES [J].
KANE, DJ ;
SARAFIAN, TA ;
ANTON, R ;
HAHN, H ;
GRALLA, EB ;
VALENTINE, JS ;
ORD, T ;
BREDESEN, DE .
SCIENCE, 1993, 262 (5137) :1274-1277
[36]   DIFFUSE LEWY BODY DISEASE IN JAPAN [J].
KOSAKA, K .
JOURNAL OF NEUROLOGY, 1990, 237 (03) :197-204
[37]   NEUROTRANSMITTERS IN BASAL GANGLIA AND CORTEX OF ALZHEIMERS-DISEASE WITH AND WITHOUT LEWY BODIES [J].
LANGLAIS, PJ ;
THAL, L ;
HANSEN, L ;
GALASKO, D ;
ALFORD, M ;
MASLIAH, E .
NEUROLOGY, 1993, 43 (10) :1927-1934
[38]   PROSPECTS FOR CLINICALLY TOLERATED NMDA ANTAGONISTS - OPEN-CHANNEL BLOCKERS AND ALTERNATIVE REDOX STATES OF NITRIC-OXIDE [J].
LIPTON, SA .
TRENDS IN NEUROSCIENCES, 1993, 16 (12) :527-532
[39]   LEVODOPA-NONRESPONSIVE LEWY BODY PARKINSONISM - CLINICOPATHOLOGICAL STUDY OF 2 CASES [J].
MARK, MH ;
SAGE, JI ;
DICKSON, DW ;
SCHWARZ, KO ;
DUVOISIN, RC .
NEUROLOGY, 1992, 42 (07) :1323-1327
[40]   BETA-AMYLOID PRECURSOR PROTEIN METABOLITES AND LOSS OF NEURONAL CA2+ HOMEOSTASIS IN ALZHEIMERS-DISEASE [J].
MATTSON, MP ;
BARGER, SW ;
CHENG, B ;
LIEBERBURG, I ;
SMITHSWINTOSKY, VL ;
RYDEL, RE .
TRENDS IN NEUROSCIENCES, 1993, 16 (10) :409-414